Quick Heal Technologies passes all resolutions at 31st AGM
- All four resolutions passed at Quick Heal Technologies' 31st AGM held on September 23, 2026
- Richard Stiennon re-appointed as Non-Executive Independent Director for a second five-year term starting September 27, 2026
- Total votes polled stood at 39,052,529, representing 71.96% of outstanding shares
- Statutory and secretarial audit reports for FY26 contained no qualifications or adverse remarks
*this image is generated using AI for illustrative purposes only.
Quick Heal Technologies passed all four resolutions at its 31st Annual General Meeting held on September 23, 2026, with 39,052,529 votes polled, representing 71.96% of total outstanding shares.
The meeting was conducted via Video Conferencing and Other Audio-Visual Means, starting at 11:30 am and concluding at 1:10 pm. A total of 63 members attended the virtual session, comprising 7 from the promoter and promoter group and 56 from the public. The total number of shareholders on the record date of September 17, 2026 stood at 63,195. Chairman Kailash Katkar briefed shareholders on the company's operations, business performance, and key achievements for FY26. Remote e-voting facilities were provided through MUFG Intime India Private Limited from September 19 to September 22, 2026.
Resolutions passed
All four resolutions were approved with requisite majority, as confirmed by the scrutinizer's report submitted on September 24, 2026. The following items were transacted:
| Resolution | Type | Status |
|---|---|---|
| Adoption of Financial Statements (Standalone & Consolidated) | Ordinary | Passed |
| Appointment of Sanjay Katkar as Director | Ordinary | Passed |
| Remuneration to Non-Executive Independent Directors | Ordinary | Passed |
| Re-appointment of Richard Stiennon as Independent Director | Special | Passed |
The statutory auditors' report and secretarial auditor report for FY26 did not contain any qualifications, observations, or adverse remarks. Consequently, these reports were not read out during the proceedings.
Detailed voting results
The scrutinizer, Jayavant B. Bhave of J. B. Bhave & Co., Company Secretaries, submitted the consolidated e-voting results covering remote e-voting and e-voting at the AGM. The following tables detail the outcome for each resolution.
Resolution 1: Adoption of financial statements
| Category | Shares held | Votes polled | % polled | Votes in favour | Votes against | % in favour | % against |
|---|---|---|---|---|---|---|---|
| Promoter and Promoter Group | 38,786,353 | 38,786,353 | 100.00 | 38,786,353 | 0 | 100.00 | 0.00 |
| Public Institutions | 226,820 | 164,763 | 72.64 | 164,763 | 0 | 100.00 | 0.00 |
| Public Non Institutions | 15,260,407 | 101,413 | 0.66 | 101,201 | 212 | 99.79 | 0.21 |
| Total | 54,273,580 | 39,052,529 | 71.96 | 39,052,317 | 212 | 100.00 | 0.00 |
Resolution 2: Appointment of Sanjay Katkar as director
| Category | Shares held | Votes polled | % polled | Votes in favour | Votes against | % in favour | % against |
|---|---|---|---|---|---|---|---|
| Promoter and Promoter Group | 38,786,353 | 38,786,353 | 100.00 | 38,786,353 | 0 | 100.00 | 0.00 |
| Public Institutions | 226,820 | 164,763 | 72.64 | 151,631 | 13,132 | 92.03 | 7.97 |
| Public Non Institutions | 15,260,407 | 101,413 | 0.66 | 101,150 | 263 | 99.74 | 0.26 |
| Total | 54,273,580 | 39,052,529 | 71.96 | 39,039,134 | 13,395 | 99.97 | 0.03 |
Resolution 3: Remuneration to non-executive independent directors
| Category | Shares held | Votes polled | % polled | Votes in favour | Votes against | % in favour | % against |
|---|---|---|---|---|---|---|---|
| Promoter and Promoter Group | 38,786,353 | 38,786,353 | 100.00 | 38,786,353 | 0 | 100.00 | 0.00 |
| Public Institutions | 226,820 | 164,763 | 72.64 | 164,763 | 0 | 100.00 | 0.00 |
| Public Non Institutions | 15,260,407 | 101,153 | 0.66 | 100,603 | 550 | 99.46 | 0.54 |
| Total | 54,273,580 | 39,052,269 | 71.95 | 39,051,719 | 550 | 100.00 | 0.00 |
Resolution 4: Re-appointment of Richard Stiennon as non-executive independent director
| Category | Shares held | Votes polled | % polled | Votes in favour | Votes against | % in favour | % against |
|---|---|---|---|---|---|---|---|
| Promoter and Promoter Group | 38,786,353 | 38,786,353 | 100.00 | 38,786,353 | 0 | 100.00 | 0.00 |
| Public Institutions | 226,820 | 164,763 | 72.64 | 152,125 | 12,638 | 92.33 | 7.67 |
| Public Non Institutions | 15,260,407 | 101,413 | 0.66 | 100,572 | 841 | 99.17 | 0.83 |
| Total | 54,273,580 | 39,052,529 | 71.96 | 39,039,050 | 13,479 | 99.97 | 0.03 |
Director appointment details
Shareholders approved the re-appointment of Richard Stiennon as Non-Executive Independent Director for a second term of five consecutive years, effective from September 27, 2026, to September 26, 2031. Stiennon is the Chief Research Analyst at ITHarvest, a firm he founded in 2005, and serves on the advisory board of several startups. He is the author of Security Yearbook 2025 and Guardians of the Machine Age, among other publications on cybersecurity and digital defense. He holds a Bachelor of Science in Aerospace Engineering and an MA in War in the Modern World from King's College, London. The company confirmed that Stiennon is not related to any other director and is not debarred from holding office by SEBI or any other authority.
Management updates
Management provided an overview of the global cybersecurity landscape and the evolving threat environment. The presentation outlined the company's approach to strengthening cybersecurity measures and protecting customers. Key areas discussed included product development, business transformation, marketing strategies, people and culture initiatives, and overall growth opportunities in the cybersecurity market. Shareholders raised queries regarding operations, business performance, and growth strategy, which the Chairman and management team addressed to the satisfaction of attendees.
Historical Stock Returns for Quick Heal Technologies
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +1.93% | +10.02% | -3.67% | -11.37% | -56.39% | 0.0% |
How will the appointment of Sanjay Katkar as Director influence Quick Heal's strategic direction and succession planning for the promoter group?
What specific product development or market expansion initiatives were highlighted in the FY26 performance briefing that could drive future revenue growth?
Given the low institutional voting turnout, how might Quick Heal improve shareholder engagement and institutional investor confidence in upcoming quarters?
17
Access Market Heat-map & Insights 
Create, Save & Share your Screener 
Use 200+ Screening Filters 
